Profil
Mr. Steven Tuch is a Managing Director & Co-Head of Healthcare Equity Capital Markets at Mizuho Securities USA LLC.
Mr. Tuch was previously employed as a Chief Financial Officer & Executive Vice President by vTv Therapeutics, Inc. and a Head-Corporate Development by Rallybio Corp.
He received his undergraduate degree from the University of Michigan and an MBA from Stanford Graduate School of Business.
Aktiva positioner av Steven Tuch
| Företag | Position | Start |
|---|---|---|
Mizuho Securities USA LLC
Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Direktör för Forskning - Aktier | 2025-03-01 |
Tidigare kända positioner av Steven Tuch
| Företag | Position | Slut |
|---|---|---|
| VTV THERAPEUTICS INC. | Finansdirektör/CFO | 2025-03-21 |
| RALLYBIO CORPORATION | Företagsledare/Principal | 2022-01-01 |
Steven Tuchs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Mizuho Securities USA LLC
Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vTv Therapeutics, Inc.
vTv Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company which engages in discovery and development of orally administered small molecule drugs for treating metabolic and inflammatory disorders | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
















